How much does Brivaracetam cost? What are the prices of the different versions?

Brivaracetam (Brivaracetam) is an anticonvulsant drug used to treat epilepsy, mainly for the treatment of partial seizures. The original drug of this drug has been launched in overseas markets, but it has not yet been officially launched in China. Therefore, domestic patients are temporarily unable to purchase Brivaracetam directly through conventional channels. For domestic patients, if they need it, they may need to obtain it through imported drug channels or overseas purchasing.

In overseas markets, Brivaracetam has been approved and launched, especially in the United States, Europe and other regions. Taking the U.S. market as an example, the original research version of Brivaracetam is 50mg*60 tablets, and the price is approximately 4,000 multiple RMB. This price is relatively high for patients, especially for epilepsy patients who need to take it for a long time. The cost of drugs may become a large financial burden during the treatment process. However, some patients may still be willing to bear this cost due to the drug's promising efficacy in treating epilepsy.

Currently, since Brivaracetam has not yet been marketed in China, domestic patients can only obtain the drug through imported drugs or overseas purchasing. In China, Brivaracetam is not included in domestic medical insurance, and there is no formal drug approval procedure. Therefore, for patients who need this drug, the purchase process may face certain legal and logistical challenges other than through imported drug channels. In addition, patients should ensure the quality and source of medicines when choosing these informal channels to avoid purchasing fake and shoddy products.

The price of Brivaracetam also varies between different countries and regions. For example, in Europe and the United States, the price of brivaracetam may fluctuate due to differences in drug pricing policies and market demand. In some developed countries, the price of brivaracetam is relatively expensive due to the drug's patent protection and high production costs. In some developing countries or generic drug markets, if a generic version of the drug appears, the price may drop. Nonetheless, since brivaracetam is not yet available in China, domestic patients still have limited options and must rely on imported channels to obtain the drug.

Reference materials:https://www.briviact.com/